This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
CNBC
cnbc.com
did:plc:m7ks2xhfuku7errrtfjux2lg
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
https://cnb.cx/4faARQ3
2026-07-20T02:00:15.765Z